Headquartered in Bethesda, Maryland, near the nation's capital, Orano USA is a leading technology and services provider for decommissioning shutdown nuclear energy facilities, managing used nuclear fuel, conducting federal site clean-up and closure, and the sale of uranium, conversion, and enrichment services to the U.S. commercial and federal markets. In the nuclear medicine field, Orano Med is developing a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb), a rare alpha-emitting radioisotope and one of the more potent therapeutic payloads against cancer cells.

Orano has chosen to use their own WebEx link for the Spotlight session. Please use the link below:

Orano USA Spotlight Session Survey Results and Price Drawing Visit Session


Resources

To access session resources, you must be logged in and registered for the meeting.

Register NowLog In